To see or not to see

Summary form only given. Vision is the primary sense used in daily life. How do we "see" the world? Do we actually "see" it or rather "perceive" it? Or is it one and the same thing? How do people with optical eye defects perceive the world? Can normally sighted people partake in their experience? If you are blind or become blind, are you blind forever? On Earth and in the spaceflight environment, there are many effects and conditions that may impair your vision or lead to irreversible vision loss or blindness, especially if undetected. The human eye and vision system can be likened to a camera consisting of an optical lens system (cornea and eye lens), film or sensor (retina), and an image-processing unit (retina and visual cortex). The malfunctioning of only one of these components will impair your vision. This paper will touch on the above topics and have (some of) the answers.

[1]  B. Caramelli,et al.  Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial , 2006 .

[2]  Vassyl A. Lonchyna,et al.  Central venous pulsations associated with a falsely low oxygen saturation measured by pulse oximetry , 2005, Journal of Clinical Monitoring.

[3]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[4]  I. Hamilton-Craig,et al.  Statin‐associated myopathy , 2001, The Medical journal of Australia.

[5]  S. Barker.  Problems with forehead reflectance pulse oximetry. , 2006, Respiratory care.

[6]  S. Grundy,et al.  ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. , 2002, Stroke.

[7]  P. Lawrence.  Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery , 2004 .

[8]  R. Brandes,et al.  Withdrawal of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Elicits Oxidative Stress and Induces Endothelial Dysfunction in Mice , 2002, Circulation research.

[9]  Lorri A. Lee,et al.  Trends in Anesthesia-related Death and Brain Damage: A Closed Claims Analysis , 2006, Anesthesiology.

[10]  G. S. Agashe,et al.  Forehead Pulse Oximetry: Headband Use Helps Alleviate False Low Readings Likely Related to Venous Pulsation Artifact , 2006, Anesthesiology.

[11]  R. Stout,et al.  The Effect of Venous Pulsation on the Forehead Pulse Oximeter Wave Form as a Possible Source of Error in Spo2 Calculation , 2005, Anesthesia and analgesia.

[12]  F W Cheney,et al.  The American Society of Anesthesiologists Closed Claims Project: what have we learned, how has it affected practice, and how will it affect practice in the future? , 1999 .

[13]  Y. Hayashi,et al.  Malignant Hyperthermia in Japan: Mutation Screening of the Entire Ryanodine Receptor Type 1 Gene Coding Region by Direct Sequencing , 2006, Anesthesiology.

[14]  J. Tinker,et al.  Role of monitoring devices in prevention of anesthetic mishaps: a closed claims analysis. , 1989, Anesthesiology.

[15]  G. Janvier,et al.  Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients treated with statins. , 2002, Anesthesiology.

[16]  Helen Burstin,et al.  Relation between negligent adverse events and the outcomes of medical-malpractice litigation. , 1996 .

[17]  Eric Jougla,et al.  Survey of Anesthesia-related Mortality in France , 2006, Anesthesiology.

[18]  R. Laaksonen,et al.  Low-density lipoprotein-independent effects of statins. , 1999, Current opinion in lipidology.

[19]  P. Allen,et al.  Pharmacologic and Functional Characterization of Malignant Hyperthermia in the R163C RyR1 Knock-in Mouse , 2006, Anesthesiology.

[20]  L. Tiret,et al.  Complications associated with anaesthesiaa — prospective survey in France , 1986, Canadian Anaesthetists' Society journal.

[21]  Jeroen J. Bax,et al.  Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. , 2005, The American journal of cardiology.

[22]  R. Robinson,et al.  Mutations in RYR1 in malignant hyperthermia and central core disease , 2006, Human mutation.

[23]  A. M. Lefer,et al.  Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. , 2001, Cardiovascular research.

[24]  Relationship between malpractice litigation and human errors. , 1999, Anesthesiology.

[25]  B. Riedel,et al.  Improved Postoperative Outcomes Associated with Preoperative Statin Therapy , 2006, Anesthesiology.

[26]  Ann G. Lawthers,et al.  Relation between malpractice claims and adverse events due to negligence. Results of the Harvard Medical Practice Study III. , 1991 .

[27]  A. Covacci,et al.  Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia , 2006, Human mutation.

[28]  Y. Auroy,et al.  French Survey of Anesthesia in 1996 , 2000 .

[29]  D. Reich,et al.  Predictors of Pulse Oximetry Data Failure , 1996, Anesthesiology.